Metraipolis › archive › dc_f3e301bfbc71

A novel multiomics machine learning signature identifies rapid progression in clinically low risk prostate cancer — Europe PMC PMID:42736338

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42736338
DOI: 10.1038/s41746-[numero omesso]-5
License (as archived): solo-consultazione
Archived: 2026-10-15T15:12:43.371Z
SHA-256 of the archived text: af304e295b68838fd28392fbc6e6955f67fcfac69c77b079653e6017f9b66eed
Stable URL of this page: https://metraipolis.com/documento/dc_f3e301bfbc71

How to cite

A novel multiomics machine learning signature identifies rapid progression in clinically low risk prostate cancer — Europe PMC PMID:42736338 — Europe PMC (en), https://europepmc.org/article/MED/42736338 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3e301bfbc71 (Metraipolis archive dc_f3e301bfbc71, sha256 af304e295b68838fd28392fbc6e6955f67fcfac69c77b079653e6017f9b66eed)

BibTeX

@misc{dcf3e301bfbc71,
  title = {A novel multiomics machine learning signature identifies rapid progression in clinically low risk prostate cancer — Europe PMC PMID:42736338},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42736338},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3e301bfbc71; sha256 af304e295b68838fd28392fbc6e6955f67fcfac69c77b079653e6017f9b66eed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42736338. Agents can read the archived copy with the MCP tool read_document.